CJMB
CALLAN JMB INC.
$0.7700
+7.54%
$4.0M
No data for this timeframe.
Vol
Market Cap$4.0M
Cap SizeNano Cap
Inst. Holders3 funds
Inst. Value$12.7K
Inst. Activity1 buys / 0 sells
Insider Activity2B / 0S
Insider Net $$43.9K
Reddit Sentiment42° Neutral
SEC Reports1
Recent Activity
Apr 21, 2026
SEC
Callan JMB reported full-year 2025 financial results with revenue declining 12.7% year-over-year to $5.72 million and ne
8-K — Impact 7/10
Apr 17, 2026
other
Callan JMB Issues Statement on Recently Filed Lawsuit by Eddie Patent Holdings LLC
<p align="justify"><strong>Spring Branch, TX, April 17, 2026 (GLOBE NEWSWIRE) -- </strong>Callan J
Mar 20, 2026
Insider
Croyle David J bought 10,195 shares
Chief Medical Officer @ $1.75 ($17.8K)
Mar 6, 2026
Insider
Croyle David J bought 14,805 shares
Chief Medical Officer @ $1.76 ($26.1K)
Inst.
RENAISSANCE TECHNOLOGIES LLC — NEW
11,400 shares ($12.7K)
Inst.
UBS Group AG — NEW
27,568 shares ($141.3K)
Top Institutional Holders
| Fund | Value | Move |
|---|---|---|
| RENAISSANCE TECHNOLOGIES LLC | $12.7K | NEW |
| MORGAN STANLEY | $13.00 | — |
| BANK OF AMERICA CORP | $13.00 | — |
Recent Insider Trades
| Date | Insider | Type | Value |
|---|---|---|---|
| Mar 20, 2026 | Croyle David | BUY | $17.8K |
| Mar 6, 2026 | Croyle David | BUY | $26.1K |
Reddit Sentiment
42°▼
Neutral
Bearish
Neutral
Bullish
3 institutional holders with $12.7K total value (11,424 shares) as of 2025-Q4. Top holders: RENAISSANCE, MORGAN, BANK. Net buying activity: 1 institutions added/increased vs 0 reduced.
Top Institutional Holders — 2025-Q4
| # | Fund | Shares | Value | % of Tracked | Last Move |
|---|---|---|---|---|---|
| 1 | RENAISSANCE TECHNOLOGIES LLC | 11,400 | $12.7K | 99.8% | NEW |
| 2 | MORGAN STANLEY | 12 | $13.00 | 0.1% | — |
| 3 | BANK OF AMERICA CORP /DE/ | 12 | $13.00 | 0.1% | — |
Recent Position Changes
| Fund | Action | Prev Shares | Curr Shares | Change % | Value | Quarter |
|---|---|---|---|---|---|---|
| RENAISSANCE TECHNOLOGIES LLC | NEW | — | 11,400 | — | $12.7K | 2025-Q4 |
| UBS Group AG | NEW | — | 27,568 | — | $141.3K | 2025-Q2 |
1 unique insiders with 2 transactions. Net insider value: $43.9K ($43.9K bought, $0.00 sold).
Insider Transactions
| Date | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Mar 20, 2026 | Croyle David J | Chief Medical Officer | BUY | 10,195 | $1.75 | $17.8K |
| Mar 6, 2026 | Croyle David J | Chief Medical Officer | BUY | 14,805 | $1.76 | $26.1K |
1 SEC filing reports analyzed. Sentiment: 0 bullish, 1 bearish, 0 mixed, 0 neutral. Avg impact: 7.0/10.
No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.
Earnings Estimates & Revisions
| Period | EPS Avg | EPS Low | EPS High | EPS Growth | 30d Rev. | Up/Down | Rev. Avg | Rev. Growth | Analysts |
|---|---|---|---|---|---|---|---|---|---|
| Current Q | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Next Q | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Current FY | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Next FY | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.
42°
Neutral
Bearish
Neutral
Bullish
8 mentions
2 bullish
4 bearish
8 time periods
Reddit Sentiment History
| Date | Mentions | Sentiment | Bullish | Bearish | Threads |
|---|---|---|---|---|---|
| Mar 19, 2026 | 1 | 40° Cool | 0 | 1 | 1 |
| Mar 19, 2026 | 1 | 40° Cool | 0 | 1 | 1 |
| Mar 18, 2026 | 1 | 50° Neutral | 0 | 0 | 1 |
| Mar 18, 2026 | 1 | 50° Neutral | 0 | 0 | 1 |
| Mar 15, 2026 | 1 | 60° Warm | 1 | 0 | 1 |
| Mar 15, 2026 | 1 | 60° Warm | 1 | 0 | 1 |
| Mar 13, 2026 | 1 | 40° Cool | 0 | 1 | 1 |
| Mar 13, 2026 | 1 | 40° Cool | 0 | 1 | 1 |
Recent Reddit Threads
$CJMB critical cold logistics gamble
▲ 1
💬 1
⚡ 0.5
$CJMB – The Side of War Nobody’s Talking About
▲ 1
💬 1
⚡ 0.5
Apr 17, 2026
other
Callan JMB Issues Statement on Recently Filed Lawsuit by Eddie Patent Holdings LLC
<p align="justify"><strong>Spring Branch, TX, April 17, 2026 (GLOBE NEWSWIRE) -- </strong>Callan JMB Inc. (NASDAQ: CJMB) (“Callan JMB” or the “Compa
Apr 7, 2026
other
Callan JMB Successfully Deploys Rapid Redistribution of Critical Pharmaceuticals to Combat Localized Disease Outbreaks for Longstanding Customer
<p align="center"><i>Reverse Distribution Coordination Delivered Necessary Medical Supplies to Requesting Jurisdictions through its Established Emerge
Mar 27, 2026
other
Callan JMB Supports U.S. Scale-Up of Multi-Indication Immune Platform with Phase 2b/3 Advancement
<p align="center"><i>Independent oversight reinforces manufacturing, supply chain integrity, and federal readiness for a platform designed to scale ac
Mar 11, 2026
other
Callan JMB Inc. to Oversee Manufacturing and Quality Control of Attune Biotech’s IND Clinical Trials for lodonal™ in the Treatment of Long COVID
<p align="center"><i>Callan JMB will Provide Independent Manufacturing Oversight and Governance as lodonal<sup>™</sup> Undergoes Clinical Trials for U
Mar 2, 2026
other
Callan JMB CEO, Wayne Williams Invited to Attend the 50th International GMP Conference on March 2-5, 2026
<p align="justify"><b>SPRING BRANCH, Texas, March 02, 2026 (GLOBE NEWSWIRE) -- </b>Callan JMB Inc. (NASDAQ: CJMB), (“Callan JMB” or the “Company”),